Choose A when
BPC-157
Tendon/joint recovery, GI regeneration, nerve injury. Oral option is a plus.
See full profileComparison
The two leading regenerative peptides, but for different tissues. BPC-157 acts at the vascular and motile tissue level (tendons, GI tract, nerves). GHK-Cu acts at the matrix level — skin, fasciae, hair, wound healing.
| Spec | A BPC-157 | B GHK-Cu |
|---|---|---|
| Primary mechanism | Angiogenesis via VEGFR2 + NO | Collagen synthesis + Cu²⁺ delivery |
| Primary tissue | Tendons, GI tract, nerves, joints | Skin, fasciae, hair |
| Length | 15 AA | 3 AA (tripeptide) |
| Origin | Gastric juice (Sikiric, Zagreb) | Natural plasma tripeptide (Pickart) |
| Age-related decline | Not applicable (synthetic) | Yes — 60% decline age 20 to 60 |
| Administration | s.c. daily or oral | Topical 0.05-0.2% or s.c. |
| Gastric stability | Yes | Not systemically |
| Gene regulation | Not described in literature | Modulates 4000+ genes (31% of the genome) |
Choose A when
Tendon/joint recovery, GI regeneration, nerve injury. Oral option is a plus.
See full profileChoose B when
Skin regeneration, anti-aging, wound healing, hair loss. Strong antioxidant activity.
See full profileVerdict
Different mechanisms for different tissues. Often combined in recovery protocols — BPC drives vasculature, GHK-Cu builds matrix. Together they cover the full regenerative cycle.
Other comparisons